Sign up USA
Proactive Investors - Run By Investors For Investors

Pressure BioSciences announces 1-for-30 stock consolidation

The consolidation will take effect from Monday and will bump up each share's value while reducing the number of shares in issue
Rising share price chart
After the reverse split, there will be around 1.06mln shares in issue

Pressure Biosciences Inc. ( OTCMKTS:PBIO ) has announced a one-for-thirty reverse split of its common stock to take effect next Monday.

The shares underlying the company's outstanding convertible securities will also be adjusted accordingly, the laboratory instruments designer told investors.

The reverse split will have the effect of reducing the number of shares each shareholder owns while at the same time increasing the value of each share, effectively leaving the value of each shareholder’s stake unchanged.

Once the reverse split - also known as a consolidation - has taken place, there will be around 1.06mln Pressure Bio shares in issue.

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

ventripoint_device.png
June 21 2017
The device can give accurate and rapid volumetric information about all four chambers of the heart
1507647205_biotech_517925923.jpg
October 10 2017
Last month the group revealed its Barocycler 2320EXTREME device had been selected as a finalist in the prestigious R&D 100 Awards for 2017.
diagram of the human microbiome
September 13 2017
OptiBiotix is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use